14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.07 $1.07 Wednesday, 6th Dec 2023 SURF stock ended at $1.07. During the day the stock fluctuated 0% from a day low at $1.07 to a day high of $1.07.
90 days $1.01 $1.09
52 weeks $0.555 $1.12

Historical Surface Oncology Inc. prices

Date Open High Low Close Volume
May 14, 2018 $14.02 $14.06 $13.38 $13.39 152 928
May 11, 2018 $14.19 $14.73 $13.60 $14.05 159 405
May 10, 2018 $14.41 $14.68 $13.76 $13.98 133 762
May 09, 2018 $14.94 $14.95 $14.10 $14.41 227 739
May 08, 2018 $14.59 $14.89 $14.35 $14.79 113 081
May 07, 2018 $14.36 $14.49 $13.55 $14.36 204 891
May 04, 2018 $14.52 $14.89 $13.78 $13.89 108 429
May 03, 2018 $14.86 $15.19 $14.42 $14.58 196 885
May 02, 2018 $14.62 $15.14 $14.28 $15.06 298 284
May 01, 2018 $14.34 $14.63 $14.21 $14.63 129 063
Apr 30, 2018 $14.40 $14.52 $14.10 $14.35 474 587
Apr 27, 2018 $13.76 $14.41 $13.38 $14.29 443 643
Apr 26, 2018 $13.31 $13.92 $13.06 $13.81 278 985
Apr 25, 2018 $12.89 $13.40 $12.74 $13.33 367 322
Apr 24, 2018 $12.99 $13.30 $12.08 $12.95 808 752
Apr 23, 2018 $13.50 $13.99 $12.55 $12.88 523 508
Apr 20, 2018 $13.32 $14.01 $13.32 $13.81 788 944
Apr 19, 2018 $14.75 $14.75 $13.00 $13.33 4 121 061
Click to get the best stock tips daily for free!

About Surface Oncology Inc.

Surface Oncology. Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine... SURF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT